Australia, Feb. 10 -- Actelion Pharmaceuticals Ltd., owns the trademark (2605264) for 'ELVUZO' till Sept. 5, 2035.
Status: protected:
Registered/protected
Class: 5 [Pharmaceutical preparations for treatment of cardiovascular and pulmonary diseases.]
Type of Mark: Word
Date of Acceptance: Dec. 1, 2025
Registration Advertised: Feb. 9
For further details contact Actelion Pharmaceuticals Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2605264.
Disclaimer: Curated by HT Syndication.
